Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers
Clinical trial NCT00913666 · COMPLETED
Trial details
- NCT number
- NCT00913666
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.